• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov24
Gossamer Bio Inc. to Attend Piper Sandler Annual Healthcare Conference
21:01
Nov6
Gossamer Bio released FY2025 9 Months Earnings on November 5, 2025 (EST) with actual revenue of USD 34.67 M and EPS of USD -0.543
04:00
Gossamer Bio released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 13.29 M (forecast USD 6.381 M), actual EPS USD -0.2115 (forecast USD -0.1871)
04:00
Nov5
Gossamer Bio Inc. updates seralutinib development for pulmonary hypertension
21:37
Sep22
Gossamer Bio to Present Scientific Reports on Seralutinib at ERS Congress
11:31
Aug6
Gossamer Bio released FY2025 Q2 earnings on August 5 (EST), actual revenue USD 11.49 M (forecast USD 5.409 M), actual EPS USD -0.1699 (forecast USD -0.1749)
03:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 13.29 M, Net Income -48.22 M, EPS -0.2115

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 11.49 M, Net Income -38.27 M, EPS -0.1699

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 9.889 M, Net Income -36.64 M, EPS -0.1615

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
WAI
3.360
+32.28%
+0.820
View More